Stay updated on Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial
Sign up to get notified when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.

Latest updates to the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page
- Check2 days agoChange DetectedThe study plan section was updated to replace and augment several safety and efficacy endpoints with standardized definitions (e.g., DLT rate by CTCAE v5.0, ORR by RECIST v1.1, and PFS/OS) and to include a comprehensive set of pharmacokinetic endpoints. Older endpoint definitions (per-dose-level DLT rate, peak PK measures, and certain PK analyses) were removed and clarified to align with current terminology.SummaryDifference1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new revision tag 'Revision: v3.5.4' was added and the previous 'Revision: v3.5.3' was removed, indicating a deployment/build update reflected on the page.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page footer revision identifier has been updated from v3.5.2 to v3.5.3, indicating a site/display software revision rather than a change to the clinical trial record content.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision history updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.0%

- Check80 days agoChange DetectedAdded revision tag `v3.5.0` to the page's revision history. Removed the previous revision tag `v3.4.3` from the revision history.SummaryDifference0.0%

- Check95 days agoChange DetectedRevision: v3.4.3 was added, replacing the previous Revision: v3.4.2. This is a minor site version update and does not alter study content.SummaryDifference0.0%

Stay in the know with updates to Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.